Intratubular germ cell neoplasia of unclassified type

Analytical and Quantitative Cytology and Histology

Volumn 28, Issue 3, 2006, Pages 157-170

  Del Vecchio, M Teresa ^a   Epistolato, M Carmela ^a   Tripodi, Sergio A ^a   Montironi, Rodolfo ^b   Giordano, Antonio ^a,c  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

Carcinoma in situ; Neoplasia, intratubular germ cell; Neoplasia, intratubular testicular; Testis germ cell tumor

Indexed keywords

CELL DNA;

ARTICLE; CANCER INVASION; CARCINOMA IN SITU; CELL MATURATION; CELL SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME XQ; CRYPTORCHISM; EMBRYO DEVELOPMENT; ENVIRONMENTAL FACTOR; GENE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOMIC INSTABILITY; GERM CELL TUMOR; HUMAN; INTRATUBULAR GERM CELL NEOPLASIA OF UNCLASSIFIED TYPE; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PHENOTYPE; PLURIPOTENT STEM CELL; PRECANCER; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; RISK FACTOR; SERTOLI CELL; TESTIS DEVELOPMENT; TESTIS TUMOR; TETRAPLOIDY; TGCT1 GENE; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; GENETICS; GERM CELL; GONADAL DYSGENESIS; MALE; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

GERM CELLS; GONADAL DYSGENESIS; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; RISK FACTORS; SERTOLI CELLS; TESTICULAR NEOPLASMS;

EID: 33747187836     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (103)

1. Oosterhuis JW, Looijenga LH: Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: Highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis, APMIS 2003;111:280-289
2. Skakkebaek NE: Abnormal morphology of germ cells in two infertile men. Acta Pathol Microbiol Scand [A] 1972;80:374-378
3. Skakkebaek NE: Possible carcinoma-in-situ of the testis, Lancet 1972;2:516-517
4. Giwercman A, Muller J, Skakkebaek NE: Prevalence of carcinoma in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 1991;145:77-80
5. Gondos B, Migliozzi JA: Intratubular germ cell neoplasia. Semin Diagn Pathol 1987;4:292-303
6. Scully RE: Testis. In The Pathology of Incipient Neoplasia. Second edition. Edited by DE A-SJ Henson. Philadelphia, WB Saunders, 1993, pp 384-400
7. Montironi R: Intratubular germ cell neoplasia of the testis: Testicular intraepithelial neoplasia. Eur Urol 2002;41:651-654
8. Srigley JR, Mackay B, Toth P, Ayala A: The ultrastructure and histogenesis of male germ neoplasia with emphasis on seminoma with early carcinomatous features. Ultrastruct Pathol 1988;12:67-86
9. Ulbright TM, Roth LM: Testicular and paratesticular neoplasms. In Diagnostic Surgical Pathology. Edited by SSE Sternberg. New York, Raven Press, 1994, pp 1885-1947
10. Rothe M, Albers P, Wernert N: Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours. J Pathol 1999;188:389-394
11. Marks A, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R: Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 1999;80:569-578
12. Kang JL, Rajpert-De Meyts E, Wiels J, Skakkebaek NE: Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ. Virchows Arch 1995;426:369-374
13. Drescher B, Lauke H, Hartmann M, Davidoff MS, Zumkeller W: Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGFII and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. Mol Pathol 1997;50:298-303
14. Kang JL, Meyts ER, Skakkebaek NE: Immunoreactive neuron-specific enolase (NSE) is expressed in testicular carcinoma-in-situ. J Pathol 1996;178:161-165
15. Jorgensen N, Muller J, Jaubert F, Clausen OP, Skakkebaek NE: Heterogeneity of gonadoblastoma germ cells: Similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology 1997;30:177-186
16. Mostert MM, van de Pol M, van Echten J, Olde Weghuis D, Geurts van Kessel A, Oosterhuis JW, Looijenga LH: Fluorescence in situ hybridization-based approaches for detection of 12p overrepresentation, in particular i(12p), in cell lines of human testicular germ cell tumors of adults. Cancer Genet Cytogenet 1996;87:95-102
17. Mostert MM, van de Pol M, Olde Weghuis D, Suijkerbuijk RF, Geurts van Kessel A, van Echten J, Oosterhuis JW, Looijenga LH: Comparative genomic hybridization of germ cell tumors of the adult testis: confirmation of karyotypic findings and identification of a 12p-amplicon. Cancer Genet Cytogenet 1996;89:146-152
18. Looijenga LH, Rosenberg C, van Gurp RJ, Geelen E, van Echten-Arends J, de Jong B, Mostert M, Wolter Oosterhuis J: Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma. J Pathol 2000;191:187-192
19. Summersgill BM, Jafer O, Wang R, Goker H, Niculescu-Duvaz I, Huddart R, Shipley J: Definition of chromosome aberrations in testicular germ cell tumor cell lines by 24-color karyotyping and complementary molecular cytogenetic analyses. Cancer Genet Cytogenet 2001;128:120-129
20. Skakkebaek NE, Berthelsen JG, Muller J: Carcinoma-in-situ of the undescended testis. Urol Clin North Am 1982;9:377-385
21. Giwercman A, Grindsted J, Hansen B, Jensen OM, Skakkebaek NE: Testicular cancer risk in boys with maldescended testis: A cohort study. J Urol 1987;138:1214-1216
22. Slowikowska-Hilczer J, Walczak-Jedrzejowska R, Kula K: Immunohistochemical diagnosis of preinvasive germ cell cancer of the testis. Folia Histochem Cytobiol 2001;39:67-72
23. Rapley EA, Crockford GP, Easton DF, Stratton MR, Bishop DT: Localisation of susceptibility genes for familial testicular germ cell tumour. APMIS 2003;111:128-133; discussion 133-125
24. Holm NV, Skyttke A, Christensen K, Kyvik KO: Genetic epidemiological study of testicular cancer in Danish twins born 1870-1982. Copenhagen, 2002.
25. Forman D, Oliver RT, Brett AR, Marsh SG, Moses JH, Bodmer JG, Chilvers CE, Pike MC: Familial testicular cancer: A report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer 1992;65:255-262
26. Heimdal K, Olsson H, Tretli S, Flodgren P, Borresen AL, Fossa SD: Familial testicular cancer in Norway and southern Sweden, Br J Cancer 1996;73:964-969
27. Pais V, Leav I, Lau KM, Jiang Z, Ho SM: Estrogen receptor-beta expression in human testicular germ cell tumors. Clin Cancer Res 2003;9:4475-4482
28. Carreau S, Bourguiba S, Lambard S, Galeraud-Denis I, Genissel C, Levallet J: Reproductive system: Aromatase and estrogens. Mol Cell Endocrinol 2002;193:137-143
29. Saunders PT, Millar MR, Macpherson S, Irvine DS, Groome NP, Evans LR, Sharpe RM, Scobie GA: ERbeta1 and the ER-beta2 splice variant (ERbetacx/beta2) are expressed in distinct cell populations in the adult human testis. J Clin Endocrinol Metab 2002;87:2706-2715
30. Dieckmann KP, Endsin G, Pichlmeier U: How valid is the prenatal estrogen excess hypothesis of testicular germ cell cancer? A case control study on hormone-related factors. Eur Urol 2001;40:677-683; discussion 684
31. Wellejus A, Loft S: Receptor-mediated ethinylestradiolinduced oxidative DNA damage in rat testicular cells. FASEB J 2002;16:195-201
32. Sohval AR: Testicular dysgenesis in relation to neoplasm of the testicle. J Urol 1956;75:285-291
33. Skakkebaek NE, Holm M, Hoei-Hansen C, Jorgensen N, Rajpert-De Meyts E: Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: Evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS 2003;111:1-9; discussion 9-11
34. Slowikowska-Hilczer J, Romer TE, Kula K: Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype. J Androl 2003;24:270-278
35. Pike MC, Chilvers C, Peckham MJ: Effect of age at orchidopexy on risk of testicular cancer. Lancet 1986;1:1246-1248
36. Bar-Maor JA, Nissan S, Lernau OZ, Oren M, Levy E: Orchidopexy in cryptorchidism assessed by clinical, histologic and sperm examinations. Surg Gynecol Obstet 1979;148:855-859
37. Sakashita S, Koyanagi T, Tsuji I, Arikado K, Matsuno T: Congenital anomalies in children with testicular germ cell tumor. J Urol 1980;124:889-891
38. Dow JA, Mostofi FK: Testicular tumors following orchiopexy. South Med J 1967;60:193-195
39. Batata MA, Chu FC, Hilaris BS, Whitmore WF, Golbey RB: Testicular cancer in cryptorchids. Cancer 1982;49:1023-1030
40. Prener A, Engholm G, Jensen OM: Genital anomalies and risk for testicular cancer in Danish men. Epidemiology 1996;7:14-19
41. Senturia YD: The epidemiology of testicular cancer. Br J Urol 1987;60:285-291
42. United Kingdom Testicular Cancer Study Group: Aetiology of testicular cancer: Association with congenital abnormalities, age at puberty, infertility, and exercise. Br Med J 1994;308:1393-1399
43. Kierszenbaum AL: Mammalian spermatogenesis in vivo and in vitro: A partnership of spermatogenic and somatic cell lineages. Endocr Rev 1994;15:116-134
44. Brehm R, Marks A, Rey R, Kliesch S, Bergmann M, Steger K: Altered expression of connexins 26 and 43 in Sertoli cells in seminiferous tubules infiltrated with carcinoma-in-situ or seminoma. J Pathol 2002;197:647-653
45. Luo LY, Yousef G, Diamandis EP: Human tissue kallikreins and testicular cancer. APMIS 2003;111:225-232; discussion 232-223
46. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA: Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A 2003;100:13350-13355
47. Stevens LC: Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst 1967;38:549-552
48. Rajpert-De Meyts E, Bartkova J, Samson M, Hoei-Hansen CE, Frydelund-Larsen L, Bartek J, Skakkebaek NE: The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 2003;111:267-278; discussion 278-269
49. Matsui Y, Zsebo K, Hogan BL: Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992;70:841-847
50. Andrews PW: Human teratocarcinomas. Biochim Biophys Acta 1988;948:17-36
51. Franke FE, Pauls K, Metzger R, Danilov SM: Angiotensin I-converting enzyme and potential substrates in human testis and testicular tumours. APMIS 2003;111:234-243; discussion 243-234
52. Hilscher W: The genetic control and germ cell kinetics of the female and male germ line in mammals including man. Hum Reprod 1991;6:1416-1425
53. Pauls K, Fink L, Franke FE: Angiotensin-converting enzyme (CD143) in neoplastic germ cells. Lab Invest 1999;79:1425-1435
54. Oosterhuis JW, Castedo SM, de Jong B, Cornelisse CJ, Dam A, Sleijfer DT, Schraffordt Koops H: Ploidy of primary germ cell tumors of the testis: Pathogenetic and clinical relevance. Lab Invest 1989;60:14-21
55. el-Naggar AK, Ro JY, McLemore D, Ayala AG, Batsakis JG: DNA ploidy in testicular germ cell neoplasms: Histogenetic and clinical implications. Am J Surg Pathol 1992;16:611-618
56. Galitski T, Saldanha AJ, Styles CA, Lander ES, Fink GR: Ploidy regulation of gene expression. Science 1999;285:251-254
57. Comai L: Genetic and epigenetic interactions in allopolyploid plants. Plant Mol Biol 2000;43:387-399
58. Mitelman F: Recurrent chromosome aberrations in cancer. Mutat Res 2000;462:247-253
59. Walsh J, Andrews PW: Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell. APMIS 2003;111:197-210; discussion 210-191
60. Looijenga LH, Zafarana G, Grygalewicz B, Summersgill B, Debiec-Rychter M, Veltman J, Schoenmakers EF, Rodriguez S, Jafer O, Clark J, van Kessel AG, Shipley J, van Gurp RJ, Gulis AJ, Oosterhuis JW: Role of gain of 12p in germ cell tumour development. APMIS 2003;111:161-171; discussion 172-163
61. Ford JH: Translocations of chromosome 12: II. A comparison of the distribution of sites of spontaneous and induced breakages. Hum Genet 1981;58:279-281
62. Summersgill B, Osin P, Lu YJ, Huddart R, Shipley J: Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults. Br J Cancer 2001;85:213-220
63. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM: Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998;58:4721-4727
64. Looijenga LH, de Munnik H, Oosterhuis JW: A molecular model for the development of germ cell cancer. Int J Cancer 1999;83:809-814
65. Skotheim RI, Monni O, Mousses S, Fossa SD, Kallioniemi OP, Lothe RA, Kallioniemi A: New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res 2002;62:2359-2364
66. Lifschitz-Mercer B, Elliott DJ, Issakov J, Leider-Trejo L, Schreiber L, Misonzhnik F, Eisenthal A, Maymon BB: Localization of a specific germ cell marker, DAZL1, in testicular germ cell neoplasias. Virchows Arch 2002;440:387-391
67. Tian Q, Frierson HF, Jr, Krystal GW, Moskaluk CA: Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 1999;154:1643-1647
68. Looijenga LH, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ, de Gouveia Brazao CA, Weber RF, Kirkels WJ, van Dijk T, von Lindern M, Valk P, Lajos G, Olah E, Nesland JM, Fossa SD, Oosterhuis JW: Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 2003;63:7674-7678
69. Castrillon DH, Quade BJ, Wang TY, Quigley C, Crum CP: The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci U S A 2000;97:9585-9590
70. Zeeman AM, Stoop H, Boter M, Gillis AJ, Castrillon DH, Oosterhuis JW, Looijenga LH: VASA is a specific marker for both normal and malignant human germ cells. Lab Invest 2002;82:159-166
71. Hansis C, Grifo JA, Krey LC: Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod 2000;6:999-1004
72. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW: POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003;63:2244-2250
73. Siegrist S, Feral C, Chami M, Solhonne B, Mattei MG, Rajpert-De Meyts E, Guellaen G, Bulle F: hH-Rev107, a class II tumor suppressor gene, is expressed by post-meiotic testicular germ cells and CIS cells but not by human testicular germ cell tumors. Oncogene 2001;20:5155-5163
74. van Echten J, Oosterhuis JW, Looijenga LH, van de Pol M, Wiersema J, te Meerman GJ, Schaffordt Koops H, Sleijfer DT, de Jong B: No recurrent structural abnormalities apart from i(12p) in primary germ cell tumors of the adult testis. Genes Chromosomes Cancer 1995;14:133-144
75. Sandberg AA, Meloni AM, Suijkerbuijk RF: Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors. J Urol 1996;155:1531-1556
76. Rodriguez E, Houldsworth J, Reuter VE, Meltzer P, Zhang J, Trent JM, Bosl GJ, Chaganti RS: Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosomes Cancer 1993;8:230-236
77. Suijkerbuijk RF, Sinke RJ, Meloni AM, Parrington JM, van Echten J, de Jong B, Oosterhuis JW, Sandberg AA, Geurts van Kessel A: Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization. Cancer Genet Cytogenet 1993;70:85-93
78. Akama TO, Nakagawa H, Sugihara K, Narisawa S, Ohyama C, Nishimura S, O'Brien DA, Moremen KW, Millan JL, Fukuda MN: Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. Science 2002;295:124-127
79. Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-626
80. Roelofs H, Mostert MC, Pompe K, Zafarana G, van Oorschot M, van Gurp RJ, Gillis AJ, Stoop H, Beverloo B, Oosterhuis JW, Bokemeyer C, Looijenga LH: Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol 2000;157:1155-1166
81. Zafarana G, Gillis AJ, van Gurp RJ, Olsson PG, Elstrodt F, Stoop H, Millan JL, Oosterhuis JW, Looijenga LH: Coamplification of DAD-R, SOX5, and EKI1 in human testicular seminomas, with specific overexpression of DAD-R, correlates with reduced levels of apoptosis and earlier clinical manifestation. Cancer Res 2002;62:1822-1831
82. Qiao D, Zeeman AM, Deng W, Looijenga LH, Lin H: Molecular characterization of hiwi, a human member of the hiwi gene family whose overexpression is correlated to seminomas. Oncogene 2002;21:3988-3999
83. Luo LY, Rajpert-De Meyts ER, Jung K, Diamandis EP: Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br J Cancer 2001;85:220-224
84. Scorilas A, Yousef GM, Jung K, Rajpert-De Meyts E, Carsten S, Diamandis EP: Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors. Biochem Biophys Res Commun 2001;285:400-408
85. Bartkova J, Lukas C, Sorensen CS, Meyts ER, Skakkebaek NE, Lukas J, Bartek J: Deregulation of the RB pathway in human testicular germ cell tumours. J Pathol 2003;200:149-156
86. Chaganti RS, Houldsworth J: Genetics and biology of adult human male germ cell tumors. Cancer Res 2000;60:1475-1482
87. Houldsworth J, Reuter V, Bosl GJ, Chaganti RS: Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ 1997;8:293-299
88. Bartkova J, Rajpert-De Meyts E, Skakkebaek NE, Lukas J, Bartek J: Deregulation of the G1/S-phase control in human testicular germ cell tumours. Apmis 2003;111:252-265; discussion 265-256
89. Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE, Bartek J: Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours. Int J Cancer 2000;85:370-375
90. Schwartz D, Goldfinger N, Kam Z, Rotter V: p53 controls low DNA damage-dependent premeiotic checkpoint and facilitates DNA repair during spermatogenesis. Cell Growth Differ 1999;10:665-675
91. Chaganti RS, Houldsworth J: The cytogenetic theory of the pathogenesis of human adult male germ cell tumors: Review article. APMIS 1998;106:80-83; discussion 83-84
92. Quenby SM, Gazvani MR, Brazeau C, Neilson J, Lewis-Jones DI, Vince G: Oncogenes and tumour suppressor genes in first trimester human fetal gonadal development. Mol Hum Reprod 1999;5:737-741
93. Rajpert-De Meyts E, Jacobsen GK, Bartkova J, Aubry F, Samson M, Bartek J, Skakkebaek NE: The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma. Histopathology 2003;42:217-226
94. Bartkova J, Bartek J, Lukas J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J, Midgley CA, Lane DP: p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 1991;49:196-202
95. Schenkman NS, Sesterhenn IA, Washington L, Tong YA, Weghorst CM, Buzard GS, Srivastava S, Moul JW: Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors. J Urol 1995;154:617-621
96. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethe B, Lurquin C, et al: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994;40:360-369
97. Hennuy B, Reiter E, Cornet A, Bruyninx M, Daukandt M, Houssa P, N'Guyen VH, Closset J, Hennen G: A novel messenger ribonucleic acid homologous to human MAGE-D is strongly expressed in rat Sertoli cells and weakly in Leydig cells and is regulated by follitropin, lutropin, and prolactin. Endocrinology 2000;141:3821-3831
98. Aubry F, Satie AP, Rioux-Leclercq N, Rajpert-De Meyts E, Spagnoli GC, Chomez P, De Backer O, Jegou B, Samson M: MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer 2001;92:2778-2785
99. Jager E, Gnjatic S, Nagata Y, Stockert E, Jager D, Karbach J, Neumann A, Rieckenberg J, Chen YT, Ritter G, Hoffman E, Arand M, Old LJ, Knuth A: Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A 2000;97:12198-12203
100. Satie AP, Rajpert-De Meyts E, Spagnoli GC, Henno S, Olivo L, Jacobsen GK, Rioux-Leclercq N, Jegou B, Samson M: The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. Lab Invest 2002;82:775-780
101. Schreiber L, Lifschitz-Mercer B, Paz G, Yavetz H, Zadik Z, Kula K, Slowikowska-Hilczer J, Rey R, Elliott DJ, Maymon BB: Lack of RBM expression as a marker for carcinoma in situ of prepubertal dysgenetic testis. J Androl 2003;24:78-84
102. Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebaek NE, Lukas J, Bartek J: Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours. Oncogene 2001;20:5897-5902
103. Looijenga LH, Gillis AJ, van Gurp RJ, Verkerk AJ, Oosterhuis JW: X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status. Am J Pathol 1997;151581-590